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Abstract: The most commonly reported bacterial sexually transmitted infection in the United 
States is Chlamydia trachomatis which can lead to pelvic inflammatory disease, tubal infertility 
and even increased risk of cervical cancer. C. trachomatis can only survive inside of the cell and 
lives in a parasitophorous vacuole. During infection, manipulation of different protein kinases 
aid in its replication and survival processes. One such enzyme is Protein Kinase A, PKA, which 
is an essential kinase in the host cell that phosphorylates other proteins for activation. 
Misregulation of PKA signaling has been identified in the development of many cancers. Not 
much is known about the intracellular Chlamydial manipulation of host cellular kinases, such as 
PKA during the infection process. The goal of this study was to determine the extent to which C. 
trachomatis manipulates PKA during the infection process. We hypothesize that C. trachomatis 
actively manipulates PKA signaling to regulate intracellular development and survival inside the 
host. We utilized western blot analysis of whole cell lysates (HeLa cells infected with C. 
trachomatis) collected at various time points to monitor phosphorylation changes of PKA 
kinases and substrates. Protein samples collected at various times of the infection process were 
separated by SDS-PAGE and transferred to nitrocellulose membranes. These membranes were 
probed by various phosphospecific antibodies to specific host PKA kinases, specific kinase 
substrates and total PKA substrates. The use of horse-radish peroxidase conjugated secondary 
antibodies allowed for visualization via the use of chemiluminescence. The results obtained 
confirmed that PKA and PKA substrates were indeed manipulated by C. trachomatis during 
infection and specifically that PKA activity was upregulated in the latter times of infection. 
These findings conclude that PKA enzymes serve an important role for the intracellular growth 
and development of C. trachomatis. Additional studies will help to determine if expression of 
specific PKA substrates is altered during C. trachomatis infection and if misregulation of these 
specific substrates is linked with cancer development. This can have a significant impact on 
human health and may identify certain factors that increase the risk of cervical cancer after C. 
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Chlamydia trachomatis Manipulation of Protein Kinase A 
 
Chapter 1: Introduction 
1.1 Background on C𝒉𝒉lamydia trachomatis infections 
Chlamydia trachomatis is the most commonly reported sexually transmitted disease in the 
United States with 1.75 million cases reported in 2018 alone (Centers for Disease Control and 
Prevention, 2018). An estimated 2.86 million infections occur annually in the United States of 
America with a large number of those cases going unreported due to a majority of people with C. 
trachomatis infections being asymptomatic. This is why it is commonly known as ‘silent’ 
infection with only about 10% of men and 5-30% of women with laboratory-confirmed 
chlamydial infections developing symptoms. Symptoms of chlamydial infections include penile 
and vaginal discharge and bleeding, as well as painful urination and intercourse. It infects both 
men and women and can cause serious damage to women’s reproductive systems if left 
untreated. This can increase the difficulty for a pregnancy to occur and can even lead to 
permanent infertility. C. trachomatis is known to cause ectopic pregnancies (pregnancy that 
occurs outside the womb), pelvic inflammatory disease, and even increases the risk of cervical 
cancer (Josefson, 2001; Planned Parenthood, 2020). C. trachomatis infections are caused by 
vaginal, anal, and oral sex with someone who is already infected with C. trachomatis. Infections 
can also spread to babies during childbirth. Infections in both men and women can lead to 
urethritis and proctitis and may increase a person’s chances of acquiring or transmitting HIV 
(Nusbaum, Wallace, Slatt, & Kondrad, 2004). Individuals who have has C. trachomatis 
infections in the past and been treated can get infected again by having sexual contact with 
another person infected with C. trachomatis. Chlamydial infections can be easily treated with 
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antibiotics, however with many patients being asymptomatic, many cases go untreated and can 
lead to serious medical complications later. Prevention of spreading sexually transmitted diseases 
like Chlamydia can be reduced by the use of latex condoms, abstaining from sexual intercourse, 
or to be in a long-term, monogamous relationship with a partner who has been tested and known 
to be uninfected. 
 
1.2 Intracellular growth 
C. trachomatis is a Gram-negative, obligate intracellular pathogen. It infects a host cell with 
elementary bodies (EBs), which are the infectious forms of Chlamydia that are metabolically 
inactive but highly infectious. This inactive state strictly means that it cannot grow or further 
develop its lifecycle to replicate, but rather can only infect other cells. After EBs are 
endocytosed, C. trachomatis prevents lysosomal fusion and forms a parasitophorous vacuole 
called an inclusion body which is the membrane-bound compartment that houses C. trachomatis. 
This inclusion body is usually found near the nucleus of the host cell. EBs are then converted to 
reticulate bodies (RBs), which are the metabolically active and replicative form of Chlamydia 
where the inclusion grows and develops further to multiply and replicate. RBs actively make 
proteins which are required for Chlamydial growth with additional proteins also secreted via a 
Type III Secretion system. C. trachomatis redirects exocytic vesicles that are in transit from the 
Golgi apparatus to the plasma membrane for nutritional sustainability for its own growth and 
survival in the cell. These processes are aided by the help of Chlamydial inclusion membrane 
proteins (Incs) which induce the formation of different membranous vesicular compartments and 
are localized at the inclusion membrane (Mital, Miller, Dorward, Dooley, & Hackstadt, 2013). 
The RBs begin to replicate exponentially in the inclusion and secrete additional effectors to 
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control other processes in the host cell. Some examples include Translocated Actin Recruiting 
Protein (Tarp)(Clifton et al., 2004), which localizes at the plasma membrane just below 
Chlamydial attachment, and CT847, which interacts with human Grap2 cyclin D-interacting 
protein (Kleba & Stephens, 2008). Upon stress, RBs can go into a dormant persistent stage and 
transition to enlarged aberrant bodies (Wyrick, 2010). Protein synthesis is halted in this stage and 
the removal of the stress reactivates the RBs. This stress stage is not always apparent in the 
Chlamydial life cycle. Eventually the cell will begin to die as C. trachomatis takes up all the 
nutrients for itself as RBs are naturally converted back to EBs in an asynchronous fashion. These 
EBs are secreted from the host cell to infect other cells through lysis of the host cell or by 





Figure 1. The life cycle of C. trachomatis. Shown are mechanisms of entry and exit as well as 
the EBs, RBs, and the persistent form (Potroz & Cho, 2015). 
 
1.3 Host kinase manipulation by C. trachomatis 
C. trachomatis manipulates multiple different signaling pathways and recruits many different 
host proteins to the inclusion membrane including host kinases. These kinases are responsible for 
activating other proteins through phosphorylation. Phosphorylation is a process where one 
protein activates another protein by transferring a phosphate group to it. Protein phosphorylation 
can control processes ranging from development, virulence, adaptive responses through enzyme 
activity, protein localization, signal transduction, and protein oligomerization (Grangeasse, 
Nessler, & Mijakovic, 2012; Pereira, Goss, & Dworkin, 2011). Upon C. trachomatis infection, 
several host-tyrosine kinases (platelet-derived growth factor receptor (PDGFR), and Abl kinase 
are phosphorylated and recruited to the site of bacterial attachment and may function redundantly 
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in entry (Elwell, Ceesay, Kim, Kalman, & Engel, 2008; Kim, Jiang, Elwell, & Engel, 2011). Src 
family kinases are host kinases that are abundant in these kinase rich microdomains and help to 
identify where these microdomains are located on the surfaces of the of inclusions (Mital et al., 
2013). Protein Kinase C, a host cellular protein responsible for controlling phosphorylation of 
other proteins is found to be located in these Src domains (Sah, Nelson, Shaw, & Lutter, 2019). 
Interestingly, PKC phosphorylated substrates are also recruited to the Chlamydial inclusion but 
show a circumferential recruitment; not just at the Src kinase microdomains. Other host kinases 
include myosin light chain kinase and myosin phosphatase which are believed to play a part in 
Chlamydial host-cell exit mechanisms. These proteins phosphorylate and dephosphorylate 
myosin light chain respectively and are also found to be colocalized in Src domains (Lutter, 
Barger, Nair, & Hackstadt, 2013). Some host kinases thought to be responsible for the binding of 
C. trachomatis are Pkn1 and PknD (Claywell, Matschke, & Fisher, 2016). Pkn1 is predicted to 
reside in the cytoplasm and interacts with an inclusion membrane protein and PknD is an integral 
protein thought to bind to an unidentified ligand. After infection, the Chlamydial inclusion 
manipulates multiple host-cell trafficking pathways to redirect essential host-derived nutrients 
like amino acids, lipids and iron, while limiting detection by the innate immune system. These 
studies suggest that host kinase manipulation is integral to C. trachomatis infection and opens 
the door to the role of other host kinases during the infection cycle. 
 
1.4 Implication of Protein Kinase A in C. trachomatis Infection 
Kinase rich microdomains on the surface of these inclusions are where the inclusion recruits 
most of its host cell proteins/kinases. Given that multiple host kinases are known to be recruited 
to the inclusion microdomains, we predicted that C. trachomatis kinase utilization would also 
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include Protein Kinase A (PKA) similar to that of another obligate intracellular pathogen, 
Coxiella burnetii (Macdonald, Graham, Kurten, & Voth, 2014). C. burnetii has also been shown 
to utilize myosin light chain kinases similar to C. trachomatis (Hussain, Broederdorf, Sharma, & 
Voth, 2010). Which gives reason to believe that C. trachomatis might also utilize PKA similar to 
C. burnetii. PKA is a cellular protein that is involved in multiple different signaling cascade 
events ranging from cellular growth and proliferation to apoptosis, and it has even been shown to 
play a significant role in the development of different variants of cancers (Caretta & Mucignat-
Caretta, 2011; Hedrick et al., 2013). Currently, very little is known about how Chlamydia 
manipulates oncogenic signaling. 
 
1.5 Hypothesis 
We hypothesized that PKA is recruited during infection and that C. trachomatis actively 
manipulates the PKA signaling network. 
 
Chapter 2: Materials and Methods 
2.1 Cell Line and Bacterial Strain 
HeLa cells are regularly used as a model for C. trachomatis infection and were utilized for 
infection and protein collection. HeLa cells were derived from a patient with a cervical cancer on 
February 8, 1951 (Scherer, Syverton, & Gey, 1953) and grown at 37oC with 5% CO2. Chlamydia 





2.2 Aseptic Technique in Cell Culture 
Cell culture preparation was performed in a tissue culture room following all protocols of BSL2+ 
safety precautions. Tyvex gowns with gloves were sprayed with 70% ethanol and worn at all 
times in the tissue culture room. A microscope was initially used to verify cell confluence prior 
to passaging cells and prior to infection. For cell passaging and infections the media Roswell 
Park Memorial Institute (RPMI) was used. Fetal Bovine Serum (FBS) was added to new RPMI 
to a final concentration of 5% v/v (25mL of FBS was added to 500mL of RPMI). An electronic 
serological pipettor and sterilize serological pipettes were used to transfer liquids. Warmed 1X 
Phosphate-Buffered Saline (PBS; 37oC) was used to rinse cells and remove loosely adhered or 
dead cells prior to passaging and use. T25 tissue culture flasks were used to grow HeLa cells. 
Warmed trypsin (37 oC) was used to disassociate adherent cells from the surface of the flask 
while in an incubator. Roccal-D was used as a disinfectant for all solid and liquid waste prior to 
autoclaving. Sharpies were used for labeling. A biohazard waste container was used to dispose of 
other solid materials. Ethanol (70%) was used as a disinfectant on all surfaces.  
 
2.3 Cell Maintenance in Tissue Culture 
RPMI, trypsin and 1X PBS were taken from a 4oC fridge, -20°C freezer, and a room temperature 
shelf respectively, and placed in a 37°C water bath for 10-15 minutes to warm up and then dried 
off and sprayed with 70% ethanol before being placed in a Class II Type A2 Biosafety Cabinet. 
One unused, clean T-25 tissue culture flask was placed in the Class II Type A2 Biosafety 
Cabinet after being sprayed with 70% ethanol. The T12.5 flask in which HeLa cells were grown 
was taken from the incubator and checked for confluency. If cells were at 85-95% confluency, 
they would be split into new flasks or used for experiments. 
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Splitting of cells: The liquid in the T12.5 flask was poured off into the Roccal-D removing the 
dead floating cells, while leaving the live adherent cells stuck on the bottom of the flask. The 
flask was rinsed with 2-3 mLs of 1X PBS which was also poured off into the Roccal-D. Using a 
pipette gun and a 2mL pipette, .7-.8mL of trypsin was added to the T12.5 flask and then placed 
in the 37 oC incubator for five minutes. During the five minutes, the new T-25 tissue culture flask 
was labeled with “HeLa”, the passage number (in this case “P2”), the initials of the researcher, 
and the date. Twenty milliliters of RPMI was added to the new flask via a 10mL pipette. After 
five minutes, the T12.5 flask was taken out of the incubator and smacked two times, one on each 
side of the flask to thoroughly knock off all of the cells from the bottom of the flask. The exterior 
of the flask was sprayed with 70% ethanol before being put back into the Class II Type A2 
Biosafety Cabinet. Three milliliters of RPMI was added to the T12.5 flask and thoroughly 
mixed. The entirety of the T12.5 flask was poured into the new T-25 flask and the T-25 flask was 
placed in the incubator. The T12.5 flask was discarded into a biohazard waste bin, and all used 
pipettes were placed in the Roccal-D container. The surface of the hood was then thoroughly 
wiped down with 70% ethanol.  
 
For all succeeding passages, 6-8mL of 1X PBS wash was used, and 2mL of trypsin was used 
instead. After the five-minute trypsin incubation period, 8mL of RPMI was added to the trypsin 
flask and thoroughly mixed. A new T-25 flask can then receive 1-3mLs of the mixed solution. 
Less volume was passaged for longer growth times, and more volume was passaged for faster 
growth times. All remaining media in the old flask was then poured into the Roccal-D container. 
Everything else was held constant from the first passage.  
 
 14 
Splitting cells for seeding into 24 well plates: Cells were seeded in 24 well-plates in a Class II 
Type A2 Biosafety Cabinet in the tissue culture room. Instead of pouring out the rest of the 
culture left in the old flask after passaging, it was saved for seeding well-plates. First, 24 well-
plates and a 50mL conical tube were sprayed with 70% ethanol before being placed in the Class 
II Type A2 Biosafety Cabinet. RPMI was added first to the conical tube at a ratio of 10:1 when 
mixed with the culture in the old flask respectively and inverted 4-5 times to mix. One milliliter 
was then transferred to each well in the 24 well-plate. Next, the 24 well-plate was let alone for 
ten minutes before being placed in the 37 oC incubator. The Class II Type A2 Biosafety Cabinet 
surface, was then wiped down with 70% ethanol and the remaining solution was poured into the 
Roccal-D container along with the pipette tips while disposing the empty flask into a biohazard 
waste bin. 
 
2.4 Protein Sample Preparation 
HeLa cells grown in 24 well plates to a confluency of 90%, were infected with C. trachomatis 
L2/434/Bu EBs at a multiplicity of infection (MOI) of 1. Infected cells were grown in RPMI 
containing chloramphenicol (200μg/mL) or vehicle (Ethanol 1% v/v), add at 1-hour post 
infection (hpi). Infected cells were lysed at different time points during infection (4, 12, 24, 36, 
48 hpi). Mock infected HeLa cells were used as controls. Cells were washed with 1X phosphate 
buffered saline (PBS) before lysis. One hundred μL of 8M Urea supplemented with 325 
units/mL Benzoase nuclease (EMD Millipore) and 1X protease inhibitor cocktail (Thermo 
Scientific) was added per well of 24 well plates, and incubated on ice for 10 minutes. Lysate was 
collected, and 100μL of 2X Laemmli buffer was added and stored at -20°C 
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2.5 Reagents Used in Sodium Dodecyl (Lauryl) Sulfate-Polyacrylamide Gel Electrophoresis 
(SDS-PAGE) Gel Preparation 
Tris-glycine SDS-Polyacrylamide gels were made in the laboratory. The materials and recipes 
for the resolving gel solutions of 6%, 8%, 10%, 12%, and 15% are described in Table 1 and the 
5% stacking gels are described in Table 2. 
 









6%   12%  
- H2O 2.6mL  - H2O 1.6mL 
-30% acrylamide 
mix 
1.0mL  -30% acrylamide 
mix 
2.0mL 
-1.5 M Tris (pH 
8.8) 
1.3mL  -1.5 M Tris (pH 
8.8) 
1.3mL 








-TEMED 0.004mL  -TEMED 0.002mL 
     
8%   15%  




1.3mL  -30% acrylamide 
mix 
2.5mL 
-1.5 M Tris (pH 
8.8) 
1.3mL  -1.5 M Tris (pH 
8.8) 
1.3mL 








-TEMED 0.003mL  -TEMED 0.002mL 
     
10%     
- H2O 1.9mL    
-30% acrylamide 
mix 
1.7mL    
-1.5 M Tris (pH 
8.8) 
1.3mL    




0.05mL    





Table 2. Solutions for preparing 5% stacking gels for tris-glycine SDS-polyacrylamide gel 
electrophoresis. 
Solution Components Per 5mL (1mL per Gel) 
H2O 2.77mL 
30% acrylamide mix 0.83mL 
0.5 M Tris-HCl (pH 6.8) 1.26mL 
10% SDS 0.05mL 
10% ammonium persulfate 0.05mL 
TEMED 0.005mL 
 
Ninety-five percent ethanol and Kimwipes were used to get the glass spacers and plates squeaky 
clean. They were then washed with distilled H2O, wiped clean and air dried. The stacking and 
resolving gels solutions were prepared in 50mL conical tubes based on appropriate recipes in 
Tables 1 and 2. For brevity, the making of the 10% SDS is described. Per gel, 1.9 mL of H2O 
and 1.7 mL of 30% acrylamide solution were mixed. Next, the gel spacers and holders were 
assembled in a gel casting apparatus. Then 10% APS and TEMED were added to the resolving 
gel solution and mixed by slowly rotating the conical tube. Using a P1000 pipette, 1mL solutions 
were added to the top of the spacer/plate totaling 5mL per spacer/plate. One milliliter of H2O 
was immediately placed on top of the apparatus-gel mix. After the extra solution left in the 50mL 
conical tube solidified, the H2O on top of each gel was poured off. The corners of sterile paper 
towels were used to remove excess H2O from the gels. 10% APS and TEMED were added to the 
stacking gel solution and slowly mixed 4-5 times. One milliliter was added to each gel, being 
careful to avoid bubbles. Gel combs were added immediately following the stacking gel solution 
to make 10 wells per gel. After checking for polymerization by looking at the extra solution left 
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in the conical tube, the gels were placed in a clean, damp glass container. The glass container had 




SDS-PAGE was performed to separate the proteins of interest. Frozen protein samples were 
heated in a heat block set to 100°C. The protein samples were placed in the heat block for five 
minutes, and immediately placed on ice to cool for five minutes. After cooling, samples were 
centrifuged briefly for 10-15 seconds. Two SDS-PAGE gels were acquired from a 4°C fridge, 
assembled into the running modules and put inside an SDS-PAGE container apparatus. When 
running samples, the samples treated with chloramphenicol were run on a separate gel from 
those that were not treated. The SDS-PAGE container was filled with 1X SDS running buffer 
made from diluting 10X SDS running buffer (30g of Tris base, 144g of glycine, 10g of SDS and 
1000mL of H2O). When dealing with SDS, a mask was worn until it was dissolved in solution. 
Combs were then taken out of the gels. Five microliters of Super Signal Molecular Weight 
Ladder (ThermoFisher Scientific) and 5𝜇𝜇L of Kaleidoscope Protein Ladder (Biorad) were mixed 
and placed into the first well on each gel. Next to the ladder, 20𝜇𝜇L of each protein sample was 
added. SDS-PAGE was run at 125V for 1.5 hours. After 1.5 hours, a blue color at the bottom of 
the gels was verified to ensure that the proteins had been separated. The SDS-PAGE apparatus 





2.7 Western Blot 
Electroblotting was the first step in western blotting. The electroblotting container was filled 
with 1X transfer buffer which was diluted from 10X transfer buffer (30g of Tris base, and 144g 
glycine with 1000mL of H2O). Specifically, 1X transfer buffer was then made by adding 100mL 
of 10X transfer buffer to 200mL of methanol and 700mL of H2O and mixed thoroughly with a 
magnetic stir bar. Next, four filter papers, four sponges, forceps, a gel extractor, a roller, and two 
nitrocellulose membranes were soaked in 1X transfer buffer for approximately ten minutes. The 
apparatus used for electroblotting was made by placing the sponge first on the back black part of 
the apparatus, followed by filter paper. Then the gel extractor was used to cut the well tops off of 
the gels before placing it next. Forceps were then used to carefully place the nitrocellulose 
membrane on top of the gel. Filter paper went next, followed by another sponge. The roller was 
used to make sure there were no air bubbles in the sandwich. The sandwich was then fully made 
by closing and locking the apparatus. The process was repeated for the other gel as well. The 
bottom side of the sandwich faced the back of the container. An ice pack was then acquired from 
a -20°C freezer and placed in the front part of the container to ensure that the container did not 
heat up too much. The top was closed and hooked into a power supply unit and electroblotting 
was run at 100V for one hour. The apparatus was then turned off and unplugged. The ice pack 
was cleaned and placed back in the -20°C freezer. 
 
Blocking was the next step in western blotting. For blocking, two plastic containers were cleaned 
with 1X TBST (1mL of Tween 20 and 50mL of 20X TBST to 950mL of H2O). Twenty X TBST 
was made by adding 160.13g NaCl, 4.025g KCl, and 46.03g of Tris base to 1000mL H2O. The 
20X TBST mixture was then autoclaved and stored at room temperature.  The nitrocellulose 
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membranes were then placed in clean containers respectively with forceps while checking for 
protein transfer by displaying the colored protein ladder facing up. Blots were then blocked with 
10mL 5% BSA or 5% milk depending on the primary antibody used. For phosphorylated 
proteins we used 5% BSA while for non-phosphorylated proteins we used 5% milk. Five percent 
BSA and 5% milk were made by adding 2.5g BSA or 2.5g of milk respectively to 50mL of 1X 
TBST. Five percent BSA and 5% milk were stored in a 4°C fridge. Blots were then placed in a 
4°C fridge overnight. 
 
Washes and adding primary antibodies were the next steps in western blotting. After attaining 
the nitrocellulose membranes from the 4°C fridge, milk was poured out and 15mL 1X TBST was 
added. The blots were then placed on a rocker for five minutes to complete the first wash. Two 
more washes followed. Primary antibodies were then acquired based on the protein of interest. 
Primary antibody proteins used in this experiment include PKA, phosphor-PKA (p-PKA), p-
PKA substrates, GAPDH, HSP60, GSK-3𝛽𝛽, phospho-GSK-3𝛽𝛽 (p-GSK-3𝛽𝛽), CREB, and 
phospho-CREB (p-CREB) were used. PKA is the protein of interest, and upon phosphorylation, 
becomes active and thus creating p-PKA. P-PKA substrates were looked at to determine the 
activity of possible phosphorylation of subsequent proteins by PKA. GAPDH was used as a 
standard control as all HeLa cells have GAPDH. HPS60 is used as a control for cells infected 
with C. trachomatis. GSK-3𝛽𝛽 is a protein directly phosphorylated by PKA at the Serine 9 
position. CREB is another protein that is phosphorylated by PKA. It was important to note 
whether the antibodies used were rabbit or mouse antibodies. Primary antibodies were mixed 
into blocking buffer in 10mL volumes in 15mL conical tubes. Solutions were thoroughly mixed 
by slowly inverting the conical tubes 9-10 times. After the last wash was poured out, 5mL of the 
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antibody solution was placed on each blot, and blots were either placed on a rocker to evenly 
distribute the antibodies on the blot for one hour or put in a 4°C fridge overnight.  
 
Secondary antibody addition was the next step. After acquiring the blots from the fridge, the 
primary antibody solutions were poured out and followed by three washes with 1X TBST. 
Secondary anti-antibodies made from Cell Signaling Technologies (Anti-rabbit IgG, HRP-linked 
Antibody or Anti-Mouse IgG, HRP linked Antibody) were attained from a -20°C freezer to 
match the primary antibodies. Secondary anti-antibody solutions were all made in a 15mL 
conical tube with 10mL of 5% milk and 10𝜇𝜇L of the appropriate secondary anti-antibody. After 
mixing by inversion, and pouring out the last wash of 1X TBST, 5mL of the secondary anti-
antibody solution was added to the blots. Blots were placed on a rocker at the same speed as 
before for one hour or put in a 4°C fridge overnight.  
 
The final step in western blotting is developing the blot. Three more washes with 1X TBST were 
applied to each blot followed by adding fresh 1X TBST after the last wash. Blots were developed 
with Thermo Scientific (SuperSignal West Pico PLUS Chemiluminescent Substrate and 
SuperSignal West Femto). Femto was used with phosphorylated proteins as they were generally 
harder to visualize with chemiluminescence while Pico was used with non-phosphorylated 
proteins. Gloves were worn while adding 2mL of substrate via a P1000 pipette and pipette tips to 
each blot after pouring out the 1X TBST into a waste container. Substrate sat on blots for one 
minute (Pico) or five minutes (Femto) before being placed in a clean, laminated cover paper to 
keep the blot clean when placed in the imager. The imager used in this experiment was the 
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Fluorchem E FE0622 system (ProteinSimple). Exposure time varied for imaging each protein of 
interest form ten seconds to five minutes.  
 
Chapter 3: Results 
3.1 PKA substrates are altered during C. trachomatis infection 
As PKA is a kinase known to phosphorylate many host proteins (Brandt, Kenny, Rohde, 
Martinez-Quiles, & Backert, 2009; Erazo, Yee, Banfield, & Kinchington, 2011), the first round 
of experiments were aimed to see if PKA substrate phosphorylation was altered during infection 
by C. trachomatis. Phopspho-PKA substrates were looked at to determine the activity of possible 
phosphorylation of subsequent proteins by PKA. Two conditions were assessed: one where 
chloramphenicol was added to inhibit bacterial protein synthesis and another where no 
chloramphenicol was added. Chloramphenicol is a bacteriostatic antibiotic which does not kill 
the pathogen, but only inhibits growth.  Each experiment contained two controls: GAPDH and 
HSP60. GAPDH was used as a loading control to ensure that the same amount of protein sample 
was loaded into each well. GAPDH is a housekeeping gene that is found in HeLa cells and the 
presence of GAPDH verifies that each well had sample and the same amount of total protein. 
HSP60 is a heat shock protein found in C. trachomatis and is therefore used to detect the 
presence and abundance of C. trachomatis during infection. As the post infection time increased, 
so did the amount of HSP60 corresponding to increased growth of C. trachomatis. HSP60 was 
not found in any samples with chloramphenicol, verifying that C. trachomatis protein production 
and growth were impaired.  
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Assessment of PKA substrate phosphorylation along with the controls of GAPDH and HSP60 
are shown in Figure 2.  The first observation to note is that in the conditions lacking 
chloramphenicol, a trend of increased phosphorylation of PKA substrates is seen by the gradual 
increase of intensity of the dark bands on the blots. The second observation to note is that this 
increase is phosphorylation was only seen in the samples where chloramphenicol was not 
present, allowing for C. trachomatis infection to occur. This suggests that the altered PKA 
substrate phosphorylation was due to active Chlamydia infection. This is in contrast to when 
chloramphenicol was present, C. trachomatis protein synthesis is inhibited and the Chlamydia 
are unable to grow, and there is no increase in PKA substrate phosphorylation over 48 hours. 
Thus, these results show that C. trachomatis infection results in upregulation in the 
phosphorylation of PKA substrates in a time dependent manner. The results were consistent 
when two different PKA substrate antibodies were tested with both having the same outcome 
(Figure 2). Each of the two PKA substrate antibodies used detected different substrates that PKA 
phosphorylates with some overlap. P-PKA Substrate 9621 detects proteins containing a phospho-
serine/threonine residue with arginine at the -3 position which detects substrates of the ACG 
family kinases which include PKA and PKC. P-PKA Substrate 9624 is less specific and detects 
proteins containing a phospho-serine/threonine residue with arginine at both the -2 and -3 
position. Interestingly, even though most of the changes during the course of infection resulted in 
increased PKA substrate phosphorylation, there were a few proteins that appeared to decrease in 
phosphorylation as the infection progressed (Figure 2). Once again, this only occurred in 





Figure 2. Western blot analysis of phosphorylated PKA substrates during C. trachomatis 
infection. Top) Phospho-PKA substrate (9624), Bottom) Phospho-PKA Substrate (9621). 
GAPDH loading controls and HSP60 to detect C. trachomatis are shown. No chloramphenicol 
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addition shown in the left panels and chloramphenicol addition shown in the right panels. HSP60 
is not shown with the presence of chloramphenicol as there were no bands present. 
 
3.2 PKA and P-PKA levels are altered during C. trachomatis infection 
Given the substantial changes in PKA substrate phosphorylation we wanted to determine if this 
was due to overall changes in PKA protein or activated PKA (P-PKA) during infection. To do 
this, the same protein samples were analyzed by western blot using primary antibodies to PKA 
and P-PKA (an antibody detecting PKA phosphorylated at T197 which corresponds to activity 
(Cauthron, Carter, Liauw, & Steinberg, 1998)) and are shown in Figure 3.  The total amount of 
PKA seems to be uniform in both conditions (with and without the addition of chloramphenicol) 
and for the duration of experiment suggesting that C. trachomatis did not alter the total amount 
of PKA in the host cells. However, some differences can be observed with P-PKA in that the 
amount of phosphorylated PKA seems to increase in a time dependent manner when cells are 
infected with C. trachomatis. No such activity is observed when infected cells are treated with 
chloramphenicol. This shows that C. trachomatis is upregulating the phosphorylating PKA, 
albeit only moderately. 
 
  
Figure 3. Western blot analysis of Phospho-PKA (Thr197) & total PKA during C. 
trachomatis infection. Top) Phospho-PKA (Thr197), Bottom) Total PKA, Left) Lacking 
chloramphenicol, Right) Treated with chloramphenicol. 
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3.3 Phosphorylation of GSK-3𝛽𝛽 is altered during C. trachomatis infection 
There are many potential PKA substrates that can be detected using the phosphospecifc 
antibodies used in Figure 2. To verify these results, the amount of p-GSK-3𝛽𝛽 and GSK-3𝛽𝛽 were 
looked at. GSK-3𝛽𝛽 is a substrate of PKA that is phosphorylated by PKA at the site of serine 9 (Li 
et al., 2000). As the post infection time increased, the amount of p-GSK-3𝛽𝛽 increased for cells 
infected with C. trachomatis. There is no change in the infected cells treated with 
chloramphenicol. The total amount of GSK-3𝛽𝛽 is shown to be held constant in cells infected with 
C. trachomatis and mock infected cells. This shows that GSK-3𝛽𝛽 gets phosphorylated by PKA as 
the post infection time increases. 
 
 
Figure 4. Western blot analysis of Phospho-GSK-3𝛽𝛽 (Ser9) & total GSK-3𝛽𝛽 during C. 
trachomatis infection. Top) phospho-GSK-3𝛽𝛽 (Ser9), Bottom) Total GSK-3𝛽𝛽, Left) Lacking 
chloramphenicol, Right) Treated with chloramphenicol. 
 
3.4 Phosphorylation of CREB is not altered during C. trachomatis infection 
CREB is another protein that can be phosphorylated by PKA at the serine 133 position (Naqvi, 
Martin, & Arthur, 2014). The amount CREB that gets phosphorylated into P-CREB increases 
with post infection time. However, the same holds true for samples with chloramphenicol where 
C. trachomatis is not present. Therefore, one cannot deduce that the increase in P-CREB is 
caused by C. trachomatis and may simply be due to a gradual increase in cell confluency and 
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number. The amount of CREB is shown to slightly increase as post infection time increases for 
cells infected with C. trachomatis. However, no such distinction is evident in mock infected cells 
(condition with chloramphenicol). 
 
 
Figure 5. Western blot analysis Phospho-CREB (S133) & total CREB during C. 
trachomatis infection. Top) p-CREB (S133), Bottom) Total CREB, Left) Lacking 
chloramphenicol, Right) Treated with chloramphenicol. 
 
4.0 Discussion  
The results show that C. trachomatis is indeed manipulating host cellular PKA signaling. This is 
evidenced in the assessment of total PKA substrates and also a specific PKA substrate, GSK-3𝛽𝛽. 
This suggests that PKA may be used or needed in the latter parts of the C. trachomatis life cycle, 
especially since phosphorylation was time dependent. The life cycle of C. trachomatis starts with 
EBs, then goes to RBs, then back to EBs to infect other cells. Once the host cell can no longer 
provide enough nutrients for Chlamydia, the RBs get converted back to EBs to infect other cells 
via lysis of the host cell or extrusion of the EBs. Lysis of cells releases EBs all at once while the 
extrusion process consists of a budding of the host cellular membrane filled with EBs that go on 
to infect other host cells. Multiple extrusions can come from a single infected host cell. PKA 
may play a role in the activation of EBs in the extrusion process. Additional evidence gathered 
by a graduate student in the lab shows that PKA is recruited to the Src rich domains of the 
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parasitophorous vacuole and that the recruitment is time dependent with the greatest amount of 
recruitment occurring late in infection. This shows more relevance as to why it may be involved 
in the extrusion process since it is on the membrane of the Chlamydial inclusion. However, the 
extrusion process for C. trachomatis occurs at 48 hours post infection while the upregulation of 
phosphorylated PKA starts before this. Other late stage events include turning RBs back to EBs 
or transitioning to enlarged aberrant bodies for a dormant persistent stage upon stress. PKA may 
also be used for regulating transcription factors to turn genes on and off in the later stages of the 
infection process. Overall, PKA phosphorylates many proteins, so its uses may not be limited to 
one purpose.  
 
Interestingly, PKA substrates were shown to become both dephosphorylated and phosphorylated 
during the course of infection with C. trachomatis with most substrates showing a general trend 
for the latter. This raises the potential that some PKA substrates may be only needed at certain 
times during the Chlamydia life cycle and not at others. Future experiments exploring the 
temporal need of PKA substrates may provide some valuable insights perhaps into the 
requirements for the growth and differentiation of EBS to RBs and then RBs back to EBs. 
 
In a different study on another strain, C. pneumonia, GSK-3𝛽𝛽 was found to be interacting with 
an Inc (Flores & Zhong, 2015). Another study shows that GSK-3𝛽𝛽 was identified as a potential 
interacting partner for TepP in C. trachomatis (Bugalhao & Mota, 2019). TepP is a type III 
secreted effector protein for C. trachomatis. This led to the belief that C. trachomatis might 
manipulate this protein as a potential target as well. This study showed GSK-3𝛽𝛽 to have 
increased phosphorylation during the late stages of the infection cycle as well. GSK-3𝛽𝛽, like 
 29 
PKA, is also involved to phosphorylate many other proteins involved in nearly every process of 
the cell (Sutherland, 2011). This makes it hard to identify any specific reason over another as to 
what its manipulation might entail. One protein that is commonly manipulated by GSK-3𝛽𝛽 is 
glycogen synthase. After phosphorylating glycogen synthase, a reduction in glycogen synthesis 
occurs (Sutherland, 2011). This may be relevant to C. trachomatis so that it does not waste more 
energy on synthesis in order to spend it on cell exit mechanisms. Therefore, it is not surprising 
that we see an increase in GSK-3𝛽𝛽 as there are a few reasons as to why one could hypothesize C. 
trachomatis would want to manipulate GSK-3𝛽𝛽 as mentioned earlier, but we are not sure as to 
why. 
 
CREB is a protein that is also involved in many other processes in the cell as it a transcription 
factor (Wen, Sakamoto, & Miller, 2010). It is known to play key roles in cell proliferation, 
differentiation and survival. This protein was tested for upregulation in phosphorylation as post 
time infection increased because it has been shown to do so in other intracellular pathogens like 
Salmonella, Shigella, and Yersinia (Wen et al., 2010). By manipulating CREB, these pathogens 
have been able to evade the apoptotic mechanisms that macrophages use to kill abnormal cells. 
C. trachomatis is an intracellular pathogen that must evade apoptosis for its own survival, so 
CREB was measured to possibly show a reason as to how C. trachomatis evades host cellular 
apoptosis. CREB showed only a slight increase in phosphorylation in cells without 
chloramphenicol. This small increase is not substantial enough to conclude that C. trachomatis 
alters the phosphorylation of CREB. This observation falls in line with other studies. 
Specifically, Coxiella burnetii, another intracellular pathogen, has also been shown to upregulate 
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phosphorylation of PKA without altering phosphorylation of CREB (MacDonald, Kurten, & 
Voth, 2012).  
 
As mentioned earlier, altered PKA phosphorylation has been implicated in multiple variants of 
cancer, which is an uncontrolled growth of cells. Ultimately, we wanted to explore if Chlamydial 
manipulation of PKA could be a potential avenue that might link C. trachomatis to the increased 
risk of cervical cancer. This study suggests that PKA is somehow manipulated during infection, 
albeit to what end is still to be determined. More research is required to identify exact reasons for 
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